Key result
Malignant cellular clusters change their metabolic scaling exponent to less than 3/4 when maximizing energy intake, leading to a sigmoidal growth phase in higher metabolic demand.
Why the study?
To study how vascular fractality changes due to the greater demand for nutrients driven by the proliferation of cancerous tissue.
Mathematical modeling demonstrates that the metabolic scaling exponent of tumors decreases as vascular fractal dimension increases due to suboptimal alimentation and forced angiogenesis.
Hypothesis-generating for tumor energetics; does not yet support changes in clinical oncology practice.
Background: The basal metabolic rate has a scaling by tumor mass on the exponent of 3/4, while a simple surface-supplied volume of the mass would have a lower exponent, 2/3. The higher exponent can be explained by optimizing the overall energy distribution in the tumor, assuming that the target is four-dimensional. There are two possible ways of approximating the metabolic rate of the malignant tumor: 1) the volume blood-supply remains, but the surface and the length of the vessel network are modified; or 2) assuming that the malignant cell clusters try to maximize their metabolic rate to energize their proliferation by the longer length of the vessels. Our objective is to study how vascular fractality changes due to the greater demand for nutrients due to the proliferation of cancerous tissue. Results: It is shown that when a malignant tumor remains in expected four-dimensional volumetric conditions, it has a lower metabolic rate than the maximal metabolic potential in the actual demand of the proliferating cancer tissue. By maximizing the metabolic rate in malignant conditions, the allometric exponent will be smaller than 3/4, so the observed “dimensionality” of the metabolic rate versus mass becomes greater than four. The first growing period is exponential and keeps the “four-dimensional volume”, but the growth process turns to the sigmoidal phase in higher metabolic demand, and the tumor uses other optimizing strategies, further lowering the scaling exponent of metabolic rate. Conclusion: It is shown that a malignant cellular cluster changes its metabolic scaling exponent when maximizing its energy intake in various alimentary conditions.
No takes yet. Share an insight, caveat, or question.
András Szász (2021) studied Cancer. Vascular fractality and metabolic scaling was evaluated on Metabolic scaling exponent. Malignant cellular clusters change their metabolic scaling exponent to less than 3/4 when maximizing energy intake, leading to a sigmoidal growth phase in higher metabolic demand.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: